- Filed
- Nov 26, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Current Liabilities | Q3 2025 · Oct 31, 2024 | $1.85B |
| Current Liabilities | Q3 2025 · Jan 31, 2024 | $1.76B |
| Total Liabilities | Q3 2025 · Oct 31, 2024 | $2B |
| Total Liabilities | Q3 2025 · Jan 31, 2024 | $1.91B |
| Current Assets | Q3 2025 · Oct 31, 2024 | $8.53B |
| Current Assets | Q3 2025 · Jan 31, 2024 | $7.93B |
| Total Assets | Q3 2025 · Oct 31, 2024 | $10.68B |
| Total Assets | Q3 2025 · Jan 31, 2024 | $9.93B |
| Cash And Equivalents | Q3 2025 · Jan 31, 2024 | $1.56B |
| Cash And Equivalents | Q3 2025 · Oct 31, 2023 | $1.49B |
| Shares Diluted | Q3 2025 · Oct 31, 2023 | 310.39M sh |
| Shares Diluted | Q3 2025 · Oct 31, 2023 | 306.85M sh |
| Stock Repurchased | Q3 2025 · Oct 31, 2023 | $0 |
| Capex | Q3 2025 · Oct 31, 2023 | $108.41M |
| Operating Cash Flow | Q3 2025 · Oct 31, 2023 | $1.25B |
| Stockholders Equity | Q3 2025 · Oct 31, 2023 | $7.41B |
| Stockholders Equity | Q3 2025 · Jul 31, 2023 | $7B |
| Stockholders Equity | Q3 2025 · Jan 31, 2023 | $6.21B |
| Eps Diluted | Q3 2025 · Oct 31, 2023 | $0.45 |
| Eps Diluted | Q3 2025 · Oct 31, 2023 | $1.10 |
| Eps Basic | Q3 2025 · Oct 31, 2023 | $0.47 |
| Eps Basic | Q3 2025 · Oct 31, 2023 | $1.13 |
| Sga Expense | Q3 2025 · Oct 31, 2023 | $125.14M |
| Sga Expense | Q3 2025 · Oct 31, 2023 | $454.36M |
| Rd Expense | Q3 2025 · Oct 31, 2023 | $196.83M |
| Rd Expense | Q3 2025 · Oct 31, 2023 | $597.91M |
| Net Income | Q3 2025 · Oct 31, 2023 | $141.21M |
| Net Income | Q3 2025 · Oct 31, 2023 | $338.63M |
| Operating Income | Q3 2025 · Oct 31, 2023 | $169.39M |
| Operating Income | Q3 2025 · Oct 31, 2023 | $356.75M |
| Gross Profit | Q3 2025 · Oct 31, 2023 | $865.74M |
| Gross Profit | Q3 2025 · Oct 31, 2023 | $2.58B |
| Cost Of Revenue | Q3 2025 · Oct 31, 2023 | $270.99M |
| Cost Of Revenue | Q3 2025 · Oct 31, 2023 | $801.49M |
| Revenue | Q3 2025 · Oct 31, 2023 | $1.14B |
| Revenue | Q3 2025 · Oct 31, 2023 | $3.38B |